trending Market Intelligence /marketintelligence/en/news-insights/trending/4wFJKWTVaiTKcv0Rx3bvXg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Exact Sciences plans underwritten public offering for common stock

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Exact Sciences plans underwritten public offering for common stock

Exact Sciences Corp. plans to sell 7 million common shares in an underwritten public offering.

The company has also granted underwriters an option to purchase up to 1,050,000 additional shares.

Exact Sciences plans to use the net proceeds to fund the expansion of Cologuard commercialization activities including to increase laboratory, manufacturing and customer service capacity, to fund product development efforts, and for general corporate and working capital purposes.

Jefferies LLC, BofA Merrill Lynch and Robert W. Baird & Co. Inc. are acting as underwriters for the offering.